James Galloway

13.3k citations
284 papers · 5.8k · 4 hit papers · h-index 38

Impact in

  • Rheumatology top 0.1%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Hematology top 1%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Rheumatoid Arthritis Research and Therapies 122
    • Systemic Lupus Erythematosus Research 17
    • Spondyloarthritis Studies and Treatments 13

James Galloway

248 papers receiving 5.7k citations

James Galloway's Hit Papers

Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician 2024 · 68 citations
680+5+11Years since publication100200300400500

Peers

James Galloway
Comparison fields: 5 of 148
  • Rheumatology 2.4k
  • Hematology 631
  • Infectious Diseases 643
  • Immunology 678
  • Neurology 316
Replace Sindhu R. Johnson with:
Sindhu R. Johnson Canada
Sofía Ramiro Netherlands
Eloísa Bonfá Brazil
Merete Lund Hetland Denmark
María A. López-Olivo United States
Loreto Carmona Spain
Kath Watson United Kingdom
A. Zink Germany
Boulos Haraoui Canada
Andreas Kronbichler Austria
James Galloway relative to Sindhu R. Johnson Canada Sindhu R. Johnson's profile →
Citations per field
00.5×1.5×2.2×
Sindhu R. Johnson · 1×
Citations per year

Countries citing papers authored by James Galloway

Since Specialization
Citations

This map shows the geographic impact of James Galloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Galloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Galloway more than expected).

Fields of papers citing papers by James Galloway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Galloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Galloway. The network helps show where James Galloway may publish in the future.

Co-authors

The 25 scholars most cited alongside James Galloway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Galloway Line = papers co-authored together James Galloway links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 284 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
Hit paper breakdown →
2009532
2
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
Hit paper breakdown →
2010502
3
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis
Hit paper breakdown →
2019199
4 2016182
5 2011146
6 2012127
7 2020127
8 2018125
9 2020118
10 2020113
11 2012110
12 2021104
13 201797
14 201296
15 202194
16 201687
17 201885
18 202385
19 201882
20 198579

About James Galloway

James Galloway is a scholar working on Rheumatology, Epidemiology, Oncology, Hematology and Physiology, having authored 284 papers that have together received 5.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (122 papers), Systemic Lupus Erythematosus Research (17 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers), Autoimmune and Inflammatory Disorders Research (13 papers), Spondyloarthritis Studies and Treatments (13 papers), Chronic Lymphocytic Leukemia Research (12 papers), COVID-19 Clinical Research Studies (10 papers) and COVID-19 and healthcare impacts (8 papers). The work is most often cited by research in Rheumatology (2.4k citations), Hematology (631 citations), Infectious Diseases (643 citations), Immunology (678 citations) and Neurology (316 citations). James Galloway has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Kimme L Hyrich, Mark Lunt, Deborah Symmons, Kath Watson, William G Dixon, Katie Bechman, Andrew Ustianowski, Sam Norton, Sujith Subesinghe and Louise Mercer. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, The Journal of Rheumatology, RMD Open and Arthritis & Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact